Is Braskem going bankrupt? No, not yet — but the company has asked the court for a legal shield to protect itself from financial creditors while it attempts to renegotiate debt it can no longer service with its current cash flow. This is not a formal judicial reorganization (recuperação judicial), and everyday operations (factories, suppliers, clients) are running as usual. The problem is strictly financial, and it is severe: the board even authorized management to file for bankruptcy in urgent situations if necessary. The market received the message loud and clear, sending the stock down 9.32% on the same day.
What Happened
On June 25, 2026, Braskem filed for a preliminary injunction (Tutela de Urgência Cautelar) with the 2nd Bankruptcy and Judicial Reorganization Court of São Paulo. Simultaneously, it initiated mediation proceedings with the Wind Mediation Chamber. The board of directors also approved protective measures abroad, if needed, and — in the most alarming move — authorized management to file for bankruptcy in urgent situations.
The market reacted immediately: BRKM5 dropped 9.32% to close at R$ 6.91. Anyone following the company knows this is not the first blow this year. In June, Shine I (an IG4 Capital fund) took control via a tender offer (OPA), and the Federal Prosecutors' Office filed a criminal lawsuit linked to the Maceió disaster. The preliminary injunction is a new chapter — and the most delicate one financially.
What Is a Preliminary Injunction? (For the Uninitiated)
Imagine you owe money to ten people and do not have enough cash to pay everyone on time. If each person can knock on your door and demand payment at once — or worse, execute collateral, freeze accounts, or push you into bankruptcy — you will collapse before you can negotiate anything. A preliminary injunction is essentially a request asking a judge to temporarily freeze collections while a company tries to reach an agreement with creditors.
It is an instrument provided under the Brazilian Civil Procedure Code: the company demonstrates urgency (maturities looming) and risk (of a creditor run destroying value) and asks for immediate protective measures. In practice, it is a provisional legal shield. It does not solve the debt — it merely buys breathing room to negotiate without being torn apart along the way.
Why This Is NOT a Judicial Reorganization
This distinction matters greatly, and it is where most people get confused. A judicial reorganization (known in Brazil as an "RJ") is a broad, formal, and time-consuming process that involves all creditors — suppliers, banks, service providers — and places the entire company under court supervision for years. That is the stage reached when regular operations are already compromised.
Braskem's preliminary injunction is surgical: its scope is exclusively financial and targets only financial creditors (bondholders and bank debt). Suppliers, clients, and factory operations continue normally. The company has not entered an RJ — it first attempted an out-of-court restructuring (private negotiation), failed to secure enough support, and is now seeking a legal shield strictly for its financial obligations. It is an intermediate step, much more targeted than an RJ, but it signals that amicable negotiations have stalled.
Why Amicable Negotiations Stalled
IG4 Capital, the new controlling shareholder since early June (holding a 50.1% stake via the Shine I fund), and Braskem attempted to cobble together an out-of-court restructuring — a voluntary agreement with creditors outside of court. The problem was that creditors did not bite.
The reason is a classic conflict of interest between short-term and long-term creditors. The company's plan treats the two groups differently: those with debt maturing soon (short term) would receive more favorable terms, while those holding long-term debt would face worse conditions. That makes sense from the company's perspective — it needs to put out the nearest fire first — but it is precisely why long-term creditors blocked the deal: no one wants to foot the bill. Without unanimity or a qualified majority, the out-of-court restructuring goes nowhere. Hence the need for a judicial shield, which can impose terms even without unanimous consent.
The Core Proposal: Swapping Debt for More Debt (PIK)
The proposed restructuring converts all unsecured debt into new instruments relying on three levers:
| Measure | Practical Meaning |
|---|---|
| 5-year maturity extension | Pushes current maturities further out, easing immediate cash pressure. |
| 200 bps interest rate cut | Reduces the cost of debt by 2 percentage points per year, providing direct relief on financial expenses. |
| 100% PIK option (July 2026 to Dec 2028) | Allows the company to pay interest with more debt instead of cash, at its discretion. |
The centerpiece here is the PIK option (short for payment-in-kind). In practice, rather than paying interest in cash, the company can pay by issuing more debt securities. In other words, the interest expense does not disappear — it is capitalized and swells the principal balance. It is akin to paying off one credit card bill with another.
Why do this? Because Braskem simply lacks the cash to service interest right now. The PIK mechanism preserves the scant cash left to keep operations running, betting that petrochemical margins will improve in a few years and the company will return to generating cash. It is a legitimate survival strategy — but it only works if that recovery materializes. If it does not, the debt simply grows larger.
The Scale of the Hole
The numbers explain why a legal shield became necessary. Gross debt stands at $9.4 billion (adjusted net debt of $8.5 billion); altogether, that amounts to R$ 51.8 billion. Cash reserves in the first quarter of 2026 sat at roughly $1.06 billion — while 2026 maturities alone total $1.46 billion. Do the math: cash reserves do not even cover this year's maturing obligations.
Add to that a loss of R$ 10.9 billion in 2025, negative cash generation, and compressed margins from the global petrochemical industry's downturn, and the picture becomes clear. Braskem is not facing a temporary liquidity crunch; it is caught in a structural mismatch between what it owes and what it can generate. The shield buys time. Time alone, however, will not fix the problem.
What Happens If the Court Denies the Request?
The preliminary injunction is a request — and the judge can deny it. If that happens, Braskem loses its shield, and creditors become free to demand payment, execute collateral, and, ultimately, file for bankruptcy. It is precisely in this scenario that the board's authorization for management to file for bankruptcy in urgent situations carries so much weight. This detail alone underscores the severity of the situation: the company already has a Plan B, and that Plan B is the exit door.
The most likely path, however, is not an outright denial. Injunctions of this kind are usually granted, at least partially, to prevent the abrupt destruction of a company of Braskem's size (controlled by IG4/Shine I with 50.1% and Petrobras with 47%). The real risk lies less in an immediate denial and more in prolonged negotiations, ballooning debt via PIK, and the company's failure to turn cash generation around.
What This Means for BRKM5 Investors
To put it bluntly: BRKM5 shareholders are at the back of the line. In any restructuring or bankruptcy, equity holders are paid only after all creditors are made whole — and here, creditors are not even receiving full payouts. The risk for BRKM5 unitholders/shareholders is real and binary.
Optimistic scenario: the restructuring is successfully negotiated (with or without the judicial shield), PIK and maturity extensions provide breathing room, the petrochemical cycle turns around, and the company returns to generating cash. In this case, the stock — currently deeply discounted — could stage a strong recovery precisely because it has been beaten down so severely.
Pessimistic scenario: negotiations stall, debt snowballs via PIK without a recovery in margins, and the company slides toward bankruptcy. In bankruptcy, equity is at the bottom of the pile — and shares could effectively go to zero. The board's own authorization to file for bankruptcy shows that this outcome is on the table.
For current holders, the decision comes down to accepting that BRKM5 is no longer a case of a "cheap, quality company" but rather a high-risk turnaround play — the kind of bet where you can multiply your capital or lose almost everything. There is no comfortable middle ground here, and treating the stock as a defensive investment is self-deception.
Verdict: Braskem is not going bankrupt today, but it has asked the courts for the tools to survive a financial hole that its cash reserves cannot plug. The preliminary injunction is a legitimate and necessary defensive play, but the inclusion of bankruptcy authorization in the same package speaks volumes about how narrow its margins are. For investors, BRKM5 is currently an extreme-risk bet, not a steady portfolio asset.
Recent Braskem Coverage
- Federal Prosecutors' criminal lawsuit regarding Maceió (June 19, 2026)
- Tender Offer (OPA): Shine I Takes Control of Braskem (June 12, 2026)
